Lung Cancer:
Lung Cancer Symptoms, Treatment Options for Lung Cancer, Small Cell Lung Cancer, News Information on Lung Cancer.
-
Nov 2nd, 2009
A quick questionnaire administered in a doctor’s office can identify people who are at high risk for lung cancer.
-
Sep 29th, 2009
Approximately 10 percent of people who have lung cancer never smoked, and the mystery is why these individuals - mostly women - develop this disease. A new Web-based clinical trial run by researchers at Vanderbilt-Ingram Cancer Center is inviting people who have lung cancer and who never smoked to help them find the answer.
-
Sep 26th, 2009
Hormone replacement therapy, already linked to increased risk of breast cancer, heart disease and stroke, nearly doubles a woman's risk of dying from lung cancer.
-
Aug 28th, 2009
Drug giants Abbott Laboratories and Pfizer Inc. are joining forces on a project designed to match a genetic test (from Abbott Molecular, a unit of Abbott Labs) for non-small cell lung cancer (NSCLC) with a new drug to treat it. According to the American Cancer Society, 80 to 90 percent of all cases of lung cancer are the non-small cell type.
-
Jul 28th, 2009
The cause of lung cancer in never-smokers is poorly understood, but a study has identified a molecule believed to play an early and important role in its development.
-
Jul 25th, 2009
A new study, published in the in the International Journal of Cancer, looks at lung cancer and may change the common practice of removing both ovaries when a hysterectomy is done. It has become common to remove both ovaries as a way to prevent ovarian cancer.
-
Jul 13th, 2009
Roche's phase III study, called SATURN, shows great promise for Lung Cancer patients who received Tarceva (erlotinib) after chemotherapy for lung cancer treatment.
-
Jul 7th, 2009
The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer.
-
Jul 6th, 2009
Elli Lilly, which received an FDA approval for lung cancer drug Alimta, says it is the first chemotherapy approved as maintenance therapy for nonsquamous non-small cell lung cancer.
-
Jun 29th, 2009
Lung cancer remains the deadliest cancer, with 26,624 deaths in 2005, and affects mainly men (78% of 31 000 cases in 2005). However, mortality from lung cancer in humans decreases while increasing in women (+ 4.2% per year) at an alarming rate. The progression of lung cancer in women is in line with increase of smoking between 2000 and 2005. Now, the new blood test points out the early symptoms of lung cancer.